Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	183.31	1103.29	389.44
Graham Fair Price	-73.10	1.35	5.03
PEG	14233.97	0.79	< 0.005
Price/Book	-14.68	0.43	0.50
Price/Cash Flow	-33.64	-183.08	275.90
Prices/Earnings	-1071.67	-73.17	-6.24
Price/Sales	-86.72	20.51	-154.39
Price/FCF	-33.64	-183.08	275.90
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-45.90	0.28	-0.52
Operating Margin	-99.16	-0.05	6.14
ROA	92.67	< 0.005	< 0.005
ROE	-0.02	< 0.005	92.72
ROIC	-0.01	< 0.005	91.67
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	-43.44
Dividends QOQ	4.16	-0.77	-81.37
EBIT QOQ	-7.05	0.95	-86.59
EPS QOQ	-11.34	0.93	-91.83
FCF QOQ	-0.85	-2.28	-170.09
Revenue QOQ	-1.10	7.41	575.38
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-146.83	47.71	-67.51
Days Sales Outstanding (DSO)	-18991.60	2952.78	-84.45
Inventory Turnover	-0.61	1.89	207.75
Debt/Capitalization	0.42	0.42	0.33
Quick Ratio	1.04	1.04	0.42
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	7.48	7.46	-0.30
Cash	1.03	1.00	-3.41
Capex	0.01	-0.02	28.20
Free Cash Flow	0.01	-0.02	28.20
Revenue	-0.02	0.16	540.42
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.28	1.28	0.35
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	180.39	560.92	210.94
Naive Interpretation	Member

06 - Financial Health · Weak

Rating